Bausch + Lomb Corporation (NYSE/TSX:BLCO) ("Bausch + Lomb" or the "Company"), a leading global eye health company dedicated to helping people see better to live better, today announced the election of the 10 directors nominated at its 2025 Annual Meeting of Shareholders (the "Annual Meeting") held on May 21, 2025. Detailed results of the vote follow:

Name	For	Against	Broker Non-Votes
Nathalie Bernier	337,617,248	1,924,336	8,383,437
Gary Hu	337,591,706	1,949,878	8,383,437
Brett Icahn	337,474,287	2,067,297	8,383,437
Sarah B. Kavanagh	337,602,211	1,939,373	8,383,437
Karen L. Ling	337,526,114	2,015,470	8,383,437
John A. Paulson	337,650,735	1,890,849	8,383,437
Russel C. Robertson	337,600,880	1,940,704	8,383,437
Thomas W. Ross, Sr.	337,583,018	1,958,566	8,383,437
Brenton L. Saunders	337,592,062	1,949,522	8,383,437
Andrew C. von Eschenbach, M.D.	337,607,276	1,934,308	8,383,437

Shareholders also approved, in a non-binding advisory vote, the compensation of the Company's named executive officers, appointment of PricewaterhouseCoopers LLP to serve as auditor until the close of the Company's 2026 Annual Meeting of Shareholders, and authorization for the board of directors to fix the auditor's remuneration.

The final vote tabulation on all matters voted on at the Annual Meeting will be filed with the U.S. Securities and Exchange Commission on a current report on Form 8-K, and such report will be made available on the Company's SEDAR+ profile and on the Company's website at www.bausch.com.

About Bausch + Lomb

Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,500 employees and a presence in approximately 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with us on Facebook, Instagram, LinkedIn, X and YouTube.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250521597609/en/

Media Contact:

Chris Clark

chris.clark@bausch.com

(848) 360-1100

Investor Contact:

George Gadkowski

george.gadkowski@bausch.com

(877) 354-3705 (toll free)

(908) 927-0735